Outpatient Chemotherapy-Free Cancer Treatment Market

The subcutaneous segment leads the route of administration category with a 53.9% share in 2026. Hematologic malignancies account for the largest cancer type share at 34.2%, while immunotherapy leads the therapy type segment with a 33.8% share.